bpc-157 regenerative health Peptide Therapy for Muscle, Joint & Gut Peptide Therapy for Pain Management

Independent testing eliminates the conflict of interest inherent in supplier-conducted verification

10.1016/j.immuni.2005.02.004 Immunity 105 MasgrasI.Sanchez-MartinC.ColomboG.RasolaA

10.1016/j.neuint.2018.08.003 Neurochem

The week after that, closer to 1.75 mg

Andrew Huberman, a neuroscience professor at Stanford, has stated publicly that "BPC-157 is one of the more interesting peptides because of the gastric juice origin and the acid stability, but the lack of human trials is a real limitation that people tend to overlook." This sentiment reflects the tension between preclinical promise and clinical evidence gaps

Its still an experimental synthetic peptide with limited human study results